Aktis Oncology, Inc. AKTS
15.20 USD +0.26 (+1.74%)
At closeNov 4, 2026, 4:39 PM EST
15.20 0.00 0.00%
After hours · Nov 4, 4:39 PM ET
14.70 Day range 16.11
13.96 52-week range 34.19
- YTD
- -32.14%
- 1 year
- -32.14%
Financial health
Altman Z-Score
6.72 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 2
Valuation
P/E -18.8×
FY 2022 5y median -23.1× FY 2025
P/S 181×
FY 2022 5y median 90.5× FY 2025
P/B -8.0×
FY 2022 5y median -12.9× FY 2025
P/FCF -16.0×
FY 2022 5y median -19.5× FY 2025
EV/EBITDA -18.7×
FY 2022 5y median -23.3× FY 2025
EV/Sales 177×
FY 2022 5y median 88.5× FY 2025
FCF Yield -6.3%
FY 2022 5y median -3.5% FY 2025
Profitability
Gross Margin 100.0%
FY 2022 5y median 50.0% FY 2025
Operating Margin -1149.5%
FY 2022 5y median -574.8% FY 2025
Net Margin -980.9%
FY 2022 5y median -490.5% FY 2025
ROE 43.6%
FY 2022 5y median 56.0% FY 2025
ROIC -31.8%
FY 2022 5y median -23.2% FY 2025
ROA -24.1%
FY 2022 5y median -18.4% FY 2025
Growth (YoY)
Revenue 336.9%
FY 2022 FY 2025
Operating Income -43.5%
FY 2022 FY 2025
EPS (diluted) 5.6%
FY 2022 FY 2025
Free Cash Flow -719.4%
FY 2022 FY 2025
Financial Health
Current Ratio 7.4×
FY 2022 5y median 16.0× FY 2025
Quick Ratio 7.4×
FY 2022 5y median 16.0× FY 2025
Debt / Equity -0.1×
FY 2022 5y median -0.1× FY 2025
Net Debt / EBITDA 0.4×
FY 2022 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2022 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31